Skip to main content
Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0650
+0.0140 (27.45%)
Jun 5, 2025, 2:01 PM EDT

Regen BioPharma Revenue

Regen BioPharma had revenue of $59.07K in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $236.56K, down -0.00% year-over-year. In the fiscal year ending September 30, 2024, Regen BioPharma had annual revenue of $236.56K.

Revenue
236.56K
Revenue Growth
-0.00%
P/S Ratio
3.95
Revenue / Employee
236.56K
Employees
1
Market Cap
935.47K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024236.56K--
Sep 30, 2023236.56K1.04K0.44%
Sep 30, 2022235.52K64.32K37.57%
Sep 30, 2021171.19K61.19K55.63%
Sep 30, 2020110.00K--
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Elite Pharmaceuticals 70.00M
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
American Oncology Network 1.76B
Silence Therapeutics 27.70M
Revenue Rankings

Regen BioPharma News

More News